Loading…

The Views of Patients with Isolated Rapid Eye Movement Sleep Behavior Disorder on Risk Disclosure

Background Isolated rapid eye movement sleep behavior disorder (iRBD) is associated with an increased risk of Parkinson's disease and other synucleinopathies. There is no consensus about disclosure of this risk to patients with iRBD. Objective The objective of our study was to assess the experi...

Full description

Saved in:
Bibliographic Details
Published in:Movement disorders 2023-06, Vol.38 (6), p.1089-1093
Main Authors: Pérez‐Carbonell, Laura, Simonet, Cristina, Chohan, Harneek, Gill, Aneet, Leschziner, Guy, Schrag, Anette, Noyce, Alastair J.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c4443-f1eea5bfeb97d9da46b9b206bfef1332502e4914a76364ca9b3198dba09abd553
cites cdi_FETCH-LOGICAL-c4443-f1eea5bfeb97d9da46b9b206bfef1332502e4914a76364ca9b3198dba09abd553
container_end_page 1093
container_issue 6
container_start_page 1089
container_title Movement disorders
container_volume 38
creator Pérez‐Carbonell, Laura
Simonet, Cristina
Chohan, Harneek
Gill, Aneet
Leschziner, Guy
Schrag, Anette
Noyce, Alastair J.
description Background Isolated rapid eye movement sleep behavior disorder (iRBD) is associated with an increased risk of Parkinson's disease and other synucleinopathies. There is no consensus about disclosure of this risk to patients with iRBD. Objective The objective of our study was to assess the experiences of risk disclosure in a group of patients with iRBD and their views on what, when, and how this should be done. Methods A survey was administered to patients with iRBD to explore their experiences and views on risk disclosure. Results Thirty‐one patients with iRBD (28 males; mean age, 70 [SD 8.7] years; mean disease duration, 8.7 [SD 6.4] years) were included. A third reported they had not been informed about the link between iRBD and other conditions by clinicians at diagnosis, but 90% would have liked to have received prognostic information, and 60% indicated that this should happen at the point that iRBD was diagnosed. Most participants wanted this information to come from the clinician diagnosing and treating iRBD (90.3%). Almost three‐quarters (72.2%) had searched for this information online. Conclusions Patients with iRBD mostly wished to have received information regarding the potential implications of iRBD when the diagnosis was made. © 2023 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.
doi_str_mv 10.1002/mds.29403
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10947281</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2800629221</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4443-f1eea5bfeb97d9da46b9b206bfef1332502e4914a76364ca9b3198dba09abd553</originalsourceid><addsrcrecordid>eNp1kU1v1DAQhi0EokvhwB9AlrjAIe34K4lPCNoClVqB2sLVcuIJ65LEi53sav89XrZUgMRppJlHj97RS8hzBkcMgB8PLh1xLUE8IAumBCtqrqqHZAF1rQrBanVAnqR0C8CYYuVjciAqkKUEvSD2Zon0q8dNoqGjn-3kcZwS3fhpSc9T6O2Ejl7ZlXf0bIv0MqxxyAS97hFX9B0u7dqHSE99CtFhpGGkVz593y3aPqQ54lPyqLN9wmd385B8eX92c_KxuPj04fzk7UXRSilF0TFEq5oOG1057awsG91wKPOmY0JwBRylZtJWpShla3UjmK5dY0HbxiklDsmbvXc1NwO6NqeMtjer6AcbtyZYb_6-jH5pvoW1YaBlxWuWDa_uDDH8mDFNZshfYN_bEcOcDK8BSq4536Ev_0FvwxzH_F-mJDApag6Zer2n2hhSitjdp2Fgds2Z3Jz51VxmX_wZ_578XVUGjvfAxve4_b_JXJ5e75U_AXLzoy8</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2840143820</pqid></control><display><type>article</type><title>The Views of Patients with Isolated Rapid Eye Movement Sleep Behavior Disorder on Risk Disclosure</title><source>Wiley</source><creator>Pérez‐Carbonell, Laura ; Simonet, Cristina ; Chohan, Harneek ; Gill, Aneet ; Leschziner, Guy ; Schrag, Anette ; Noyce, Alastair J.</creator><creatorcontrib>Pérez‐Carbonell, Laura ; Simonet, Cristina ; Chohan, Harneek ; Gill, Aneet ; Leschziner, Guy ; Schrag, Anette ; Noyce, Alastair J.</creatorcontrib><description>Background Isolated rapid eye movement sleep behavior disorder (iRBD) is associated with an increased risk of Parkinson's disease and other synucleinopathies. There is no consensus about disclosure of this risk to patients with iRBD. Objective The objective of our study was to assess the experiences of risk disclosure in a group of patients with iRBD and their views on what, when, and how this should be done. Methods A survey was administered to patients with iRBD to explore their experiences and views on risk disclosure. Results Thirty‐one patients with iRBD (28 males; mean age, 70 [SD 8.7] years; mean disease duration, 8.7 [SD 6.4] years) were included. A third reported they had not been informed about the link between iRBD and other conditions by clinicians at diagnosis, but 90% would have liked to have received prognostic information, and 60% indicated that this should happen at the point that iRBD was diagnosed. Most participants wanted this information to come from the clinician diagnosing and treating iRBD (90.3%). Almost three‐quarters (72.2%) had searched for this information online. Conclusions Patients with iRBD mostly wished to have received information regarding the potential implications of iRBD when the diagnosis was made. © 2023 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.</description><identifier>ISSN: 0885-3185</identifier><identifier>EISSN: 1531-8257</identifier><identifier>DOI: 10.1002/mds.29403</identifier><identifier>PMID: 37046409</identifier><language>eng</language><publisher>Hoboken, USA: John Wiley &amp; Sons, Inc</publisher><subject>Aged ; autonomy ; Behavior disorders ; Brief Report ; Brief Reports ; Diagnosis ; Disclosure ; Eye movements ; Humans ; isolated REM sleep behavior disorder ; Male ; Movement disorders ; Neurodegenerative diseases ; Parkinson Disease - complications ; Parkinson Disease - diagnosis ; Parkinson Disease - epidemiology ; Parkinson's disease ; Polysomnography ; REM sleep ; REM Sleep Behavior Disorder - complications ; REM Sleep Behavior Disorder - diagnosis ; risk disclosure ; Sleep disorders ; Synucleinopathies</subject><ispartof>Movement disorders, 2023-06, Vol.38 (6), p.1089-1093</ispartof><rights>2023 The Authors. published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.</rights><rights>2023 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.</rights><rights>2023. This article is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4443-f1eea5bfeb97d9da46b9b206bfef1332502e4914a76364ca9b3198dba09abd553</citedby><cites>FETCH-LOGICAL-c4443-f1eea5bfeb97d9da46b9b206bfef1332502e4914a76364ca9b3198dba09abd553</cites><orcidid>0000-0003-3027-5497 ; 0000-0002-5555-0283 ; 0000-0002-9872-6680 ; 0000-0002-1252-6742</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,27922,27923</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37046409$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Pérez‐Carbonell, Laura</creatorcontrib><creatorcontrib>Simonet, Cristina</creatorcontrib><creatorcontrib>Chohan, Harneek</creatorcontrib><creatorcontrib>Gill, Aneet</creatorcontrib><creatorcontrib>Leschziner, Guy</creatorcontrib><creatorcontrib>Schrag, Anette</creatorcontrib><creatorcontrib>Noyce, Alastair J.</creatorcontrib><title>The Views of Patients with Isolated Rapid Eye Movement Sleep Behavior Disorder on Risk Disclosure</title><title>Movement disorders</title><addtitle>Mov Disord</addtitle><description>Background Isolated rapid eye movement sleep behavior disorder (iRBD) is associated with an increased risk of Parkinson's disease and other synucleinopathies. There is no consensus about disclosure of this risk to patients with iRBD. Objective The objective of our study was to assess the experiences of risk disclosure in a group of patients with iRBD and their views on what, when, and how this should be done. Methods A survey was administered to patients with iRBD to explore their experiences and views on risk disclosure. Results Thirty‐one patients with iRBD (28 males; mean age, 70 [SD 8.7] years; mean disease duration, 8.7 [SD 6.4] years) were included. A third reported they had not been informed about the link between iRBD and other conditions by clinicians at diagnosis, but 90% would have liked to have received prognostic information, and 60% indicated that this should happen at the point that iRBD was diagnosed. Most participants wanted this information to come from the clinician diagnosing and treating iRBD (90.3%). Almost three‐quarters (72.2%) had searched for this information online. Conclusions Patients with iRBD mostly wished to have received information regarding the potential implications of iRBD when the diagnosis was made. © 2023 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.</description><subject>Aged</subject><subject>autonomy</subject><subject>Behavior disorders</subject><subject>Brief Report</subject><subject>Brief Reports</subject><subject>Diagnosis</subject><subject>Disclosure</subject><subject>Eye movements</subject><subject>Humans</subject><subject>isolated REM sleep behavior disorder</subject><subject>Male</subject><subject>Movement disorders</subject><subject>Neurodegenerative diseases</subject><subject>Parkinson Disease - complications</subject><subject>Parkinson Disease - diagnosis</subject><subject>Parkinson Disease - epidemiology</subject><subject>Parkinson's disease</subject><subject>Polysomnography</subject><subject>REM sleep</subject><subject>REM Sleep Behavior Disorder - complications</subject><subject>REM Sleep Behavior Disorder - diagnosis</subject><subject>risk disclosure</subject><subject>Sleep disorders</subject><subject>Synucleinopathies</subject><issn>0885-3185</issn><issn>1531-8257</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><recordid>eNp1kU1v1DAQhi0EokvhwB9AlrjAIe34K4lPCNoClVqB2sLVcuIJ65LEi53sav89XrZUgMRppJlHj97RS8hzBkcMgB8PLh1xLUE8IAumBCtqrqqHZAF1rQrBanVAnqR0C8CYYuVjciAqkKUEvSD2Zon0q8dNoqGjn-3kcZwS3fhpSc9T6O2Ejl7ZlXf0bIv0MqxxyAS97hFX9B0u7dqHSE99CtFhpGGkVz593y3aPqQ54lPyqLN9wmd385B8eX92c_KxuPj04fzk7UXRSilF0TFEq5oOG1057awsG91wKPOmY0JwBRylZtJWpShla3UjmK5dY0HbxiklDsmbvXc1NwO6NqeMtjer6AcbtyZYb_6-jH5pvoW1YaBlxWuWDa_uDDH8mDFNZshfYN_bEcOcDK8BSq4536Ev_0FvwxzH_F-mJDApag6Zer2n2hhSitjdp2Fgds2Z3Jz51VxmX_wZ_578XVUGjvfAxve4_b_JXJ5e75U_AXLzoy8</recordid><startdate>202306</startdate><enddate>202306</enddate><creator>Pérez‐Carbonell, Laura</creator><creator>Simonet, Cristina</creator><creator>Chohan, Harneek</creator><creator>Gill, Aneet</creator><creator>Leschziner, Guy</creator><creator>Schrag, Anette</creator><creator>Noyce, Alastair J.</creator><general>John Wiley &amp; Sons, Inc</general><general>Wiley Subscription Services, Inc</general><scope>24P</scope><scope>WIN</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>8FD</scope><scope>FR3</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>P64</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-3027-5497</orcidid><orcidid>https://orcid.org/0000-0002-5555-0283</orcidid><orcidid>https://orcid.org/0000-0002-9872-6680</orcidid><orcidid>https://orcid.org/0000-0002-1252-6742</orcidid></search><sort><creationdate>202306</creationdate><title>The Views of Patients with Isolated Rapid Eye Movement Sleep Behavior Disorder on Risk Disclosure</title><author>Pérez‐Carbonell, Laura ; Simonet, Cristina ; Chohan, Harneek ; Gill, Aneet ; Leschziner, Guy ; Schrag, Anette ; Noyce, Alastair J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4443-f1eea5bfeb97d9da46b9b206bfef1332502e4914a76364ca9b3198dba09abd553</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Aged</topic><topic>autonomy</topic><topic>Behavior disorders</topic><topic>Brief Report</topic><topic>Brief Reports</topic><topic>Diagnosis</topic><topic>Disclosure</topic><topic>Eye movements</topic><topic>Humans</topic><topic>isolated REM sleep behavior disorder</topic><topic>Male</topic><topic>Movement disorders</topic><topic>Neurodegenerative diseases</topic><topic>Parkinson Disease - complications</topic><topic>Parkinson Disease - diagnosis</topic><topic>Parkinson Disease - epidemiology</topic><topic>Parkinson's disease</topic><topic>Polysomnography</topic><topic>REM sleep</topic><topic>REM Sleep Behavior Disorder - complications</topic><topic>REM Sleep Behavior Disorder - diagnosis</topic><topic>risk disclosure</topic><topic>Sleep disorders</topic><topic>Synucleinopathies</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Pérez‐Carbonell, Laura</creatorcontrib><creatorcontrib>Simonet, Cristina</creatorcontrib><creatorcontrib>Chohan, Harneek</creatorcontrib><creatorcontrib>Gill, Aneet</creatorcontrib><creatorcontrib>Leschziner, Guy</creatorcontrib><creatorcontrib>Schrag, Anette</creatorcontrib><creatorcontrib>Noyce, Alastair J.</creatorcontrib><collection>Wiley-Blackwell Titles (Open access)</collection><collection>Wiley-Blackwell Open Access Backfiles (Open Access)</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Movement disorders</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Pérez‐Carbonell, Laura</au><au>Simonet, Cristina</au><au>Chohan, Harneek</au><au>Gill, Aneet</au><au>Leschziner, Guy</au><au>Schrag, Anette</au><au>Noyce, Alastair J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The Views of Patients with Isolated Rapid Eye Movement Sleep Behavior Disorder on Risk Disclosure</atitle><jtitle>Movement disorders</jtitle><addtitle>Mov Disord</addtitle><date>2023-06</date><risdate>2023</risdate><volume>38</volume><issue>6</issue><spage>1089</spage><epage>1093</epage><pages>1089-1093</pages><issn>0885-3185</issn><eissn>1531-8257</eissn><abstract>Background Isolated rapid eye movement sleep behavior disorder (iRBD) is associated with an increased risk of Parkinson's disease and other synucleinopathies. There is no consensus about disclosure of this risk to patients with iRBD. Objective The objective of our study was to assess the experiences of risk disclosure in a group of patients with iRBD and their views on what, when, and how this should be done. Methods A survey was administered to patients with iRBD to explore their experiences and views on risk disclosure. Results Thirty‐one patients with iRBD (28 males; mean age, 70 [SD 8.7] years; mean disease duration, 8.7 [SD 6.4] years) were included. A third reported they had not been informed about the link between iRBD and other conditions by clinicians at diagnosis, but 90% would have liked to have received prognostic information, and 60% indicated that this should happen at the point that iRBD was diagnosed. Most participants wanted this information to come from the clinician diagnosing and treating iRBD (90.3%). Almost three‐quarters (72.2%) had searched for this information online. Conclusions Patients with iRBD mostly wished to have received information regarding the potential implications of iRBD when the diagnosis was made. © 2023 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.</abstract><cop>Hoboken, USA</cop><pub>John Wiley &amp; Sons, Inc</pub><pmid>37046409</pmid><doi>10.1002/mds.29403</doi><tpages>28</tpages><orcidid>https://orcid.org/0000-0003-3027-5497</orcidid><orcidid>https://orcid.org/0000-0002-5555-0283</orcidid><orcidid>https://orcid.org/0000-0002-9872-6680</orcidid><orcidid>https://orcid.org/0000-0002-1252-6742</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0885-3185
ispartof Movement disorders, 2023-06, Vol.38 (6), p.1089-1093
issn 0885-3185
1531-8257
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10947281
source Wiley
subjects Aged
autonomy
Behavior disorders
Brief Report
Brief Reports
Diagnosis
Disclosure
Eye movements
Humans
isolated REM sleep behavior disorder
Male
Movement disorders
Neurodegenerative diseases
Parkinson Disease - complications
Parkinson Disease - diagnosis
Parkinson Disease - epidemiology
Parkinson's disease
Polysomnography
REM sleep
REM Sleep Behavior Disorder - complications
REM Sleep Behavior Disorder - diagnosis
risk disclosure
Sleep disorders
Synucleinopathies
title The Views of Patients with Isolated Rapid Eye Movement Sleep Behavior Disorder on Risk Disclosure
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T11%3A39%3A37IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20Views%20of%20Patients%20with%20Isolated%20Rapid%20Eye%20Movement%20Sleep%20Behavior%20Disorder%20on%20Risk%20Disclosure&rft.jtitle=Movement%20disorders&rft.au=P%C3%A9rez%E2%80%90Carbonell,%20Laura&rft.date=2023-06&rft.volume=38&rft.issue=6&rft.spage=1089&rft.epage=1093&rft.pages=1089-1093&rft.issn=0885-3185&rft.eissn=1531-8257&rft_id=info:doi/10.1002/mds.29403&rft_dat=%3Cproquest_pubme%3E2800629221%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4443-f1eea5bfeb97d9da46b9b206bfef1332502e4914a76364ca9b3198dba09abd553%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2840143820&rft_id=info:pmid/37046409&rfr_iscdi=true